Impact of a peer-support programme to improve loneliness and social isolation due to COVID-19 : does adding a secure, user friendly video-conference solution work better than telephone support alone? Protocol for a three-arm randomised clinical trial

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

INTRODUCTION: The COVID-19 pandemic has forced the implementation of physical distancing and self-isolation strategies worldwide. However, these measures have significant potential to increase social isolation and loneliness. Among older people, loneliness has increased from 40% to 70% during COVID-19. Previous research indicates loneliness is strongly associated with increased mortality. Thus, strategies to mitigate the unintended consequences of social isolation and loneliness are urgently needed. Following the Obesity-Related Behavioural Intervention Trials model for complex behavioural interventions, we describe a protocol for a three-arm randomised clinical trial to reduce social isolation and loneliness.

METHODS AND ANALYSIS: A multicentre, outcome assessor blinded, three-arm randomised controlled trial comparing 12 weeks of: (1) the HOspitals WoRking in Unity ('HOW R U?') weekly volunteer-peer support telephone intervention; (2) 'HOW R U?' deliver using a video-conferencing solution and (3) a standard care group. The study will follow Consolidated Standard of Reporting Trials guidelines.We will recruit 24-26 volunteers who will receive a previously tested half day lay-training session that emphasises a strength-based approach and safety procedures. We will recruit 141 participants ≥70 years of age discharged from two participating emergency departments or referred from hospital family medicine, geriatric or geriatric psychiatry clinics. Eligible participants will have probable baseline loneliness (score ≥2 on the de Jong six-item loneliness scale). We will measure change in loneliness, social isolation (Lubben social network scale), mood (Geriatric Depression Score) and quality of life (EQ-5D-5L) at 12-14 weeks postintervention initiation and again at 24-26 weeks.

ETHICS AND DISSEMINATION: Approval has been granted by the participating research ethics boards. Participants randomised to standard care will be offered their choice of telephone or video-conferencing interventions after 12 weeks. Results will be disseminated through journal publications, conference presentations, social media and through the International Federation of Emergency Medicine.

TRIAL REGISTRATION NUMBER: NCT05228782.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

BMJ open - 14(2024), 1 vom: 09. Jan., Seite e056839

Sprache:

Englisch

Beteiligte Personen:

Lee, Jacques Simon [VerfasserIn]
Rose, Louise [VerfasserIn]
Borgundvaag, Bjug [VerfasserIn]
McLeod, Shelley L [VerfasserIn]
Melady, Donald [VerfasserIn]
Mohindra, Rohit [VerfasserIn]
Sinha, Samir K [VerfasserIn]
Wesson, Virginia [VerfasserIn]
Wiesenfeld, Lesley [VerfasserIn]
Kolker, Sabrina [VerfasserIn]
Kiss, Alex [VerfasserIn]
Lowthian, Judy [VerfasserIn]

Links:

Volltext

Themen:

ACCIDENT & EMERGENCY MEDICINE
COVID-19
Clinical Trial Protocol
GERIATRIC MEDICINE
Journal Article
MENTAL HEALTH
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 12.01.2024

Date Revised 26.01.2024

published: Electronic

ClinicalTrials.gov: NCT05228782

Citation Status MEDLINE

doi:

10.1136/bmjopen-2021-056839

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366902172